Towards predictive models of the human gut microbiome

Journal of Molecular Biology

Volumn 426, Issue 23, 2014, Pages 3907-3916

  Bucci, Vanni ^a   Xavier, Joao B ^b  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

antibiotic; biofilm; mathematical modeling; metagenomics; network inference

Indexed keywords

ARTICLE; BIOREACTOR; COMMUNITY STRUCTURE; HUMAN; INTESTINE FLORA; MATHEMATICAL MODEL; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; WHOLE CELL; BIOTA; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; THEORETICAL MODEL;

BIOTA; GASTROINTESTINAL TRACT; HUMANS; METAGENOMICS; MICROBIOTA; MODELS, THEORETICAL;

EID: 84910627912     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2014.03.017     Document Type: Review

References (88)

1. Henze M. Activated sludge models: ASM1, ASM2, ASM2d and ASM3. London, UK: IWA Publishing; 2000 9.
2. McLellan SL, Huse SM, Mueller-Spitz SR, Andreishcheva EN, Sogin ML. Diversity and population structure of sewagederived microorganisms in wastewater treatment plant influent. Environ Microbiol 2010;12:378-92.
3. Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Factories 2011;10:S10.
4. Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013;81:965-73.
5. Bassin JP, Kleerebezem R, Muyzer G, Rosado AS, van Loosdrecht MCM, Dezotti M. Effect of different salt adaptation strategies on the microbial diversity, activity, and settling of nitrifying sludge in sequencing batch reactors. Appl Microbiol Biotechnol 2012;93:1281-94.
6. Moralejo-Gárate H, Mar'atusalihat E, Kleerebezem R, van Loosdrecht MCM. Microbial community engineering for biopolymer production from glycerol. Appl Microbiol Biotechnol 2011;92:631-9.
7. Shimada T, Li X, Zilles JL, Morgenroth E, Raskin L. Effects of the antimicrobial tylosin on the microbial community structure of an anaerobic sequencing batch reactor. Biotechnol Bioeng 2011;108:296-305.
8. Leitão RC, van Haandel AC, Zeeman G, Lettinga G. The effects of operational and environmental variations on anaerobic wastewater treatment systems: a review. Bioresour Technol 2006;97:1105-18.
9. Volcke EIP, Picioreanu C, De Baets B, van Loosdrecht MCM. The granule size distribution in an anammox-based granular sludge reactor affects the conversion- implications for modeling. Biotechnol Bioeng 2012;109:1629-36.
10. Hauduc H, Rieger L, Oehmen A, van Loosdrecht M, Comeau Y, Héduit A, et al. Critical review of activated sludge modeling: state of process knowledge, modeling concepts, and limitations. Biotechnol Bioeng 2013;110:24-46.
11. Sharma KR, Corrie S, Yuan Z. Integrated modelling of sewer system and wastewater treatment plant for investigating the impacts of chemical dosing in sewers. Water Sci Technol J Int Assoc Water Pollut Res 2012;65: 1399-405.
12. Trutnau M, Petzold M, Mehlig L, Eschenhagen M, Geipel K, Müller S, et al. Using a carbon-based ASM3 EAWAG Bio-P for modelling the enhanced biological phosphorus removal in anaerobic/aerobic activated sludge systems. Bioprocess Biosyst Eng 2011;34:287-95.
13. Le Moullec Y, Potier O, Gentric C, Leclerc JP. Activated sludge pilot plant: comparison between experimental and predicted concentration profiles using three different modelling approaches. Water Res 2011;45:3085-97.
14. Majed N, Chernenko T, Diem M, Gu AZ. Identification of functionally relevant populations in enhanced biological phosphorus removal processes based on intracellular polymers profiles and insights into the metabolic diversity and heterogeneity. Environ Sci Technol 2012;46:5010-7.
15. Bucci V, Majed N, Hellweger FL, Gu AZ. Heterogeneity of intracellular polymer storage states in enhanced biological phosphorus removal (EBPR)-observation and modeling. Environ Sci Technol 2012;46:3244-52.
16. Xavier JB, De Kreuk MK, Picioreanu C, Van Loosdrecht MCM. Multi-scale individual-based model of microbial and bioconversion dynamics in aerobic granular sludge. Environ Sci Technol 2007;41:6410-7.
17. Lardon LA, Merkey BV, Martins S, Dötsch A, Picioreanu C, Kreft J-U, et al. iDynoMiCS: next-generation individualbased modelling of biofilms. Environ Microbiol 2011;13: 2416-34.
18. Whang LM, Filipe CDM, Park JK. Model-based evaluation of competition between polyphosphate- and glycogenaccumulating organisms. Water Res 2007;41:1312-24.
19. Oehmen A, Carvalho G, Lopez-Vazquez CM, Van Loosdrecht MCM, Reis MAM. Incorporating microbial ecology into the metabolic modelling of polyphosphate accumulating organisms and glycogen accumulating organisms. Water Res 2010;44: 4992-5004.
20. Lidstrom ME, Konopka MC. The role of physiological heterogeneity in microbial population behavior. Nat Chem Biol 2010;6:705-12.
21. Hellweger FL, Bucci V. A bunch of tiny individuals - individual-based modeling for microbes. Ecol Model 2009;220:8-22.
22. Stewart PS. Diffusion in biofilms. J Bacteriol 2003;185: 1485-91.
23. Picioreanu C, Kreft J-U, Van Loosdrecht MCM. Particle-based multidimensional multispecies biofilm model. Appl Environ Microbiol 2004;70:3024-40.
24. Chambless JD, Hunt SM, Stewart PS. A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl Environ Microbiol 2006;72: 2005-13.
25. Xavier JB, Foster KR. Cooperation and conflict in microbial biofilms. Proc Natl Acad Sci 2007;104:876-81.
26. Mitri S, Xavier JB, Foster KR. Social evolution in multispecies biofilms. Proc Natl Acad Sci 2011. http://dx.doi.org/10.1073/ pnas.1100292108.
27. Bucci V, Nadell CD, Xavier JB. The evolution of bacteriocin production in bacterial biofilms. Am Nat 2011;178:E162- 73.
28. Nadell CD, Bucci V, Drescher K, Levin SA, Bassler BL, Xavier JB. Cutting through the complexity of cell collectives. Proc R Soc B Biol Sci 2013;280:20122770.
29. Park S, Bae W, Rittmann BE. Multi-species nitrifying biofilm model (MSNBM) including free ammonia and free nitrous acid inhibition and oxygen limitation. Biotechnol Bioeng 2010;105:1115-30.
30. Skybová T, Pøibyl M, Pocediè J, Hasal P. Mathematical modeling of wastewater decolorization in a trickle-bed bioreactor. J Biotechnol 2012;157:512-23.
31. Martin KJ, Picioreanu C, Nerenberg R. Multidimensional modeling of biofilm development and fluid dynamics in a hydrogen-based, membrane biofilm reactor (MBfR). Water Res 2013;47:4739-51.
32. Chambless JD, Stewart PS. A three-dimensional computer model analysis of three hypothetical biofilm detachment mechanisms. Biotechnol Bioeng 2007;97:1573-84.
33. Merkey BV, Lardon LA, Seoane JM, Kreft J-U, Smets BF. Growth dependence of conjugation explains limited plasmid invasion in biofilms: an individual-based modelling study. Environ Microbiol 2011;13:2435-52.
34. Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 2011;65: 411-29.
35. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 2010;6:e1001097.
36. Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M. Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 2012;3:449-54.
37. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from entero-pathogenic infection through production of acetate. Nature 2011;469:543-7.
38. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol 2008;16:107-14.
39. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232-6.
40. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-98.
41. Blaser M, Bork P, Fraser C, Knight R, Wang J. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 2013;11:213-7.
42. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012;13:260-70.
43. Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterol 2011;45:S128-32.
44. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5:e9085.
45. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012;13:R79.
46. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010;120:4332-41.
47. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci 2011. http://dx.doi.org/10.1073/pnas.1019378108.
48. Consortium, T.H.M.P. A framework for human microbiome research. Nature 2012;486:215-21.
49. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gutmicrobiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
50. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez- Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7.
51. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 2012;8:e1002358.
52. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J 2011;5:169-72.
53. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
54. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
55. Bucci V, Bradde S, Biroli G, Xavier JB. Social interaction, noise and antibiotic-mediated switches in the intestinal microbiota. PLoS Comput Biol 2012;8:e1002497.
56. Gerber GK, Onderdonk AB, Bry L. Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol 2012;8:e1002624.
57. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, et al. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 2012;8:e1002606.
58. Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol 2012;8:e1002687.
59. Shade A, Gregory Caporaso J, Handelsman J, Knight R, Fierer N. A meta-analysis of changes in bacterial and archaeal communities with time. ISME J 2013;7:1493-506.
60. Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol 2012;10:538-50.
61. Muñoz-Tamayo R, Laroche B, Walter É, Doré J, Leclerc M. Mathematical modelling of carbohydrate degradation by human colonic microbiota. J Theor Biol 2010;266:189-201.
62. Muñoz-Tamayo R, Laroche B, Walter É, Doré J, Duncan SH, Flint HJ, et al. Kinetic modelling of lactate utilization and butyrate production by key human colonic bacterial species. FEMS Microbiol Ecol 2011;76:615-24.
63. Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, et al. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput Biol 2013;9:e1003388.
64. Schluter J, Foster KR. The evolution of mutualism in gut microbiota via host epithelial selection. PLoS Biol 2012;10: e1001424.
65. Levy R, Borenstein E. Metabolic modeling of species interaction in the human microbiome elucidates communitylevel assembly rules. Proc Natl Acad Sci U S A 2013;110: 12804-9.
66. WuH-J, Ivanov II,Darce J, Hattori K,Shima T,Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010;32:815-27.
67. White JR. Novel methods for metagenomic. Analysis 2010 [http://hdl.handle.net/1903/10292].
68. Marino S, Baxter NT, Huffnagle GB, Petrosino JF, Schloss PD. Mathematical modeling of primary succession of murine intestinal microbiota. Proc Natl Acad Sci 2014;111:439-44.
69. Fisher CK,Mehta P. Identifying keystone species in the human gut microbiome from metagenomic timeseries using sparse linear regression. http://arxiv.org/abs/1402.0511; 2014.
70. Sorribas A, Savageau MA. Strategies for representing metabolic pathways within biochemical systems theory: reversible pathways. Math Biosci 1989;94:239-69.
71. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A 2009;106:5859-64.
72. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011;333:101-4.
73. Faith JJ, Ahern PP, Ridaura VK, Cheng J, Gordon JI. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 2014;6:220ra11.
74. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905-14.
75. Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, et al. Genomic variation landscape of the human gut microbiome. Nature 2013;493:45-50.
76. Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013;152:39-50.
77. Griffiths WJ, Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009;38: 1882-96.
78. Boisvert S, Raymond F, Godzaridis É, Laviolette F, Corbeil J. Ray Meta: scalable de novo metagenome assembly and profiling. Genome Biol 2012;13:R122.
79. Namiki T, Hachiya T, Tanaka H, Sakakibara Y. MetaVelvet: an extension of Velvet assembler to de novo metagenome assembly from short sequence reads. Nucleic Acids Res 2012;40:e155.
80. Peng Y, Leung HCM, Yiu SM, Chin FYL. Meta-IDBA: a de novo assembler for metagenomic data. Bioinformatics 2011;27:i94-i101.
81. Shoaie S, Karlsson F, Mardinoglu A, Nookaew I, Bordel S, Nielsen J. Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci Rep 2013;3. http://dx.doi.org/10.1038/srep02532.
82. Leimena MM, Ramiro-Garcia J, Davids M, van den Bogert B, Smidt H, Smid EJ, et al. A comprehensive metatranscriptome analysis pipeline and its validation using human small intestine microbiota datasets. BMC Genomics 2013;14:530.
83. Greenblum S, Chiu H-C, Levy R, Carr R, Borenstein E. Towards a predictive systems-level model of the human microbiome: progress, challenges, and opportunities. Curr Opin Biotechnol 2013;24:810-20.
84. Orth JD, Thiele I, Palsson BØ. What is flux balance analysis? Nat Biotechnol 2010;28:245-8.
85. Khandelwal RA, Olivier BG, Röling WFM, Teusink B, Bruggeman FJ. Community flux balance analysis for microbial consortia at balanced growth. PLoS One 2013;8:e64567.
86. Zomorrodi AR, Maranas CD. OptCom: a multi-level optimization framework for the metabolic modeling and analysis of microbial communities. PLoS Comput Biol 2012;8:e1002363.
87. Höffner K, Harwood SM, Barton PI. A reliable simulator for dynamic flux balance analysis. Biotechnol Bioeng 2013;110: 792-802.
88. Hellweger FL. Escherichia coli adapts to tetracycline resistance plasmid (pBR322) by mutating endogenous potassium transport: in silico hypothesis testing. FEMS Microbiol Ecol 2013;83:622-31.